Your search:
615 result(s) in 0.17 s
-
DUKAS_184200799_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, left, of Oakland, is followed by a counter-protestor during a protest with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200798_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Michelle Del Cueto, 30, an organizer and photographer from Oakland, leads a chant with members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. During the event, Del Cueto was met by a counterprotestor displaying a “Eat Chicken” sign. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200796_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, of Oakland, holds their dog Nala as they demonstrate with members of the animal rights network Direct Action Everywhere (DxE) during a protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200795_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Rocky, who’s representing a chicken, stands near surveillance cameras as members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200794_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Julien Amado, of Oakland, represents a baby chicken as they demonstrate with members of the animal rights network Direct Action Everywhere (DxE) during a protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200793_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200792_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Neighbors watch members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200791_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: A counter-protester holds a “Eat Chicken” sign as they stand in front of members of the animal rights network Direct Action Everywhere (DxE) during a protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200790_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor while holding their dog Nala during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200789_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Counter-protesters hold a Trump flag and a “Eat Chicken” sign as they face members of the animal rights network Direct Action Everywhere (DxE) during a protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200788_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Counter-protesters hold a Trump flag and a “Eat Chicken” sign as they face members of the animal rights network Direct Action Everywhere (DxE) during a protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200787_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor while holding their dog Nala during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200786_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor while holding their dog Nala during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200785_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor while holding their dog Nala during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200784_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200783_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, right, of Oakland, is confronted by a counter-protestor while holding their dog Nala during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200782_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Nicky Gott, second from left, of Oakland, is confronted by a counter-protestor during a demonstration with members of the animal rights network Direct Action Everywhere (DxE) outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200780_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Michelle Del Cueto, 30, an organizer and photographer from Oakland, leads a chant with members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. During the event, Del Cueto was met by counterprotestors displaying a Trump flag and a “Eat Chicken” sign. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_184200778_POL
Protest against Perdue’s Petaluma Poultry slaughterhouse
3/22/2025 - Santa Rosa, California, USA: Members of the animal rights network Direct Action Everywhere (DxE) protest outside the home of Jason Arnold, Director of Operations for Perdue’s Petaluma Poultry slaughterhouse, in Santa Rosa, Calif. on Saturday, March 22, 2025. The group gave speeches and call-and-response chants asking Arnold to address findings of criminal animal cruelty at the Perdue slaughterhouse he oversees. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263421_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient Keith Krehbiel wears a Medtronic device during his treatment with neurologist Dr. Helen Bronte-Stewart at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263420_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Pat Wright, left, watches her partner Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, as she demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263419_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263418_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, works with neurologist Simon Little, UCSF, during a treatment with Parkinson’s patient Deb Zeyen, both not pictured, former VP in Marketing and Internet Development for CBS Television Network, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263417_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263416_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS) wears a Medtronic device during treatment with neurologist Gaurav Chattree, Stanford University, not pictured, at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263414_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263412_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), walks in a hallway during his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), and other medical professionals at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263410_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263408_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Folks gather for the International Women's Day - Unite and Resist event at Union Square in San Francisco on Saturday, March 8, 2025. People joined the cause to protect their bodies, rights and future. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263406_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart, left, and Pearl Yamaguchi, senior field clinical research manager for Medtronic, read a monitor while treating Parkinson’s patient Keith Krehbiel (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263403_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart (not pictured) works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263402_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart reads a monitor while treating Parkinson’s patient Keith Krehbiel (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263401_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263400_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263399_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263394_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, works on her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263392_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, and nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263390_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263388_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Gaurav Chattree, second from right, Stanford University, converses with Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), second from left, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263386_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Gaurav Chattree, Stanford University, monitors treatment with Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), not pictured, at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263382_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), walks in a hallway during his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), and other medical professionals at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263380_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Ken Washington, chief technology officer for Medtronic, and Rob Raike, director of research and technology for Medtronic Neuromodulation, watch live results of Parkinson’s patient John L. Lipp’s treatment with neurologist Gaurav Chattree, Stanford University (both not pictured), at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263378_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), left, displays his motor skills to neurologist Gaurav Chattree, Stanford University (center), and engineer Shrav Ravi, emerging technology field technical consultant with Medtronic, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263376_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), attends his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263373_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Donna Gow, senior deep-brain stimulation (DBS) therapy specialist, San Francisco Bay Area, Medtronic, works with Parkinson’s patient Keith Krehbiel, during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263370_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel as Pearl Yamaguchi, senior field clinical research manager for Medtronic, observes during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263369_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263368_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, drinks water during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263367_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263366_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), second from left, listens to neurologist Gaurav Chattree, not pictured, Stanford University, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
